| Adam Jason Sachs, MD | |
|
80 Seymour St, Hartford, CT 06102-8000 | |
| (516) 521-8645 | |
| Not Available |
| Full Name | Adam Jason Sachs |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 15 Years |
| Location | 80 Seymour St, Hartford, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073740429 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 53068 (Connecticut) | Primary |
| 207L00000X | Anesthesiology | 260611 (New York) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hartford Hospital | Hartford, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Integrated Anesthesia Associates Llc | 1759281165 | 373 |
News Archive
Ipsen, an innovation-driven global specialty pharmaceutical Group announces that the French regulatory authorities (Agence Française de Sécurité Sanitaire des Produits de Santé, AFSSAPS) have today granted the marketing authorization to the 6-month sustained-release formulation of Decapeptyl® (triptorelin embonate 22.5 mg) for the treatment of locally advanced and metastatic prostate cancer.
During the first Republican presidential debate of the 2012 campaign, former Gov. Tim Pawlenty reminded viewers that President Barack Obama was against a requirement that everyone buy health insurance before he was for it. Just a few years ago, Obama "promised the nation he would do health care reform focused on cost containment, he opposed the individual mandate," Pawlenty said on May 5, 2011.
VolitionRx Limited, a life sciences company focused on developing blood-based diagnostic tests for a broad range of cancer types and other conditions, today announced that it has established partnerships with two prominent market access consulting agencies, DecideumCogentia and MedPass International, to support market access of its NuQ® cancer tests across Europe.
PrognosDx Health, Inc. announced today that in an independent research study published online in the Journal of Clinical Oncology, cellular levels of histone modifications define previously unrecognized subsets of patients with pancreatic cancer with distinct epigenetic phenotypes and clinical outcomes.
› Verified 4 days ago
| Entity Name | Connecticut Children's Specialty Group, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669448882 PECOS PAC ID: 6002720117 Enrollment ID: O20031113000468 |
News Archive
Ipsen, an innovation-driven global specialty pharmaceutical Group announces that the French regulatory authorities (Agence Française de Sécurité Sanitaire des Produits de Santé, AFSSAPS) have today granted the marketing authorization to the 6-month sustained-release formulation of Decapeptyl® (triptorelin embonate 22.5 mg) for the treatment of locally advanced and metastatic prostate cancer.
During the first Republican presidential debate of the 2012 campaign, former Gov. Tim Pawlenty reminded viewers that President Barack Obama was against a requirement that everyone buy health insurance before he was for it. Just a few years ago, Obama "promised the nation he would do health care reform focused on cost containment, he opposed the individual mandate," Pawlenty said on May 5, 2011.
VolitionRx Limited, a life sciences company focused on developing blood-based diagnostic tests for a broad range of cancer types and other conditions, today announced that it has established partnerships with two prominent market access consulting agencies, DecideumCogentia and MedPass International, to support market access of its NuQ® cancer tests across Europe.
PrognosDx Health, Inc. announced today that in an independent research study published online in the Journal of Clinical Oncology, cellular levels of histone modifications define previously unrecognized subsets of patients with pancreatic cancer with distinct epigenetic phenotypes and clinical outcomes.
› Verified 4 days ago
| Entity Name | Integrated Anesthesia Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881636397 PECOS PAC ID: 1759281165 Enrollment ID: O20040112000163 |
News Archive
Ipsen, an innovation-driven global specialty pharmaceutical Group announces that the French regulatory authorities (Agence Française de Sécurité Sanitaire des Produits de Santé, AFSSAPS) have today granted the marketing authorization to the 6-month sustained-release formulation of Decapeptyl® (triptorelin embonate 22.5 mg) for the treatment of locally advanced and metastatic prostate cancer.
During the first Republican presidential debate of the 2012 campaign, former Gov. Tim Pawlenty reminded viewers that President Barack Obama was against a requirement that everyone buy health insurance before he was for it. Just a few years ago, Obama "promised the nation he would do health care reform focused on cost containment, he opposed the individual mandate," Pawlenty said on May 5, 2011.
VolitionRx Limited, a life sciences company focused on developing blood-based diagnostic tests for a broad range of cancer types and other conditions, today announced that it has established partnerships with two prominent market access consulting agencies, DecideumCogentia and MedPass International, to support market access of its NuQ® cancer tests across Europe.
PrognosDx Health, Inc. announced today that in an independent research study published online in the Journal of Clinical Oncology, cellular levels of histone modifications define previously unrecognized subsets of patients with pancreatic cancer with distinct epigenetic phenotypes and clinical outcomes.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Adam Jason Sachs, MD 99 E River Dr, East Hartford, CT 06108-3288 Ph: (860) 282-4022 | Adam Jason Sachs, MD 80 Seymour St, Hartford, CT 06102-8000 Ph: (516) 521-8645 |
News Archive
Ipsen, an innovation-driven global specialty pharmaceutical Group announces that the French regulatory authorities (Agence Française de Sécurité Sanitaire des Produits de Santé, AFSSAPS) have today granted the marketing authorization to the 6-month sustained-release formulation of Decapeptyl® (triptorelin embonate 22.5 mg) for the treatment of locally advanced and metastatic prostate cancer.
During the first Republican presidential debate of the 2012 campaign, former Gov. Tim Pawlenty reminded viewers that President Barack Obama was against a requirement that everyone buy health insurance before he was for it. Just a few years ago, Obama "promised the nation he would do health care reform focused on cost containment, he opposed the individual mandate," Pawlenty said on May 5, 2011.
VolitionRx Limited, a life sciences company focused on developing blood-based diagnostic tests for a broad range of cancer types and other conditions, today announced that it has established partnerships with two prominent market access consulting agencies, DecideumCogentia and MedPass International, to support market access of its NuQ® cancer tests across Europe.
PrognosDx Health, Inc. announced today that in an independent research study published online in the Journal of Clinical Oncology, cellular levels of histone modifications define previously unrecognized subsets of patients with pancreatic cancer with distinct epigenetic phenotypes and clinical outcomes.
› Verified 4 days ago
Phillip Dennen, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 114 Woodland St, Hartford, CT 06105 Phone: 860-714-6654 Fax: 860-714-8110 | |
Frank J Setter, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 114 Woodland St, Hartford, CT 06105 Phone: 860-714-6654 Fax: 860-714-8110 | |
Nitish Gupta, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 80 Seymour St, Hartford, CT 06106 Phone: 860-545-5000 | |
Ethan Kim, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 80 Seymour St, Hartford, CT 06106 Phone: 860-545-5000 | |
Roxanne Zarmsky, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 114 Woodland St, Hartford, CT 06105 Phone: 860-714-6654 Fax: 860-714-8110 | |
Dr. Saadia Zafar, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 114 Woodland St, Hartford, CT 06105 Phone: 860-714-6654 |